# Study of ORIC-101 in Healthy Adult Subjects

> **NCT03324555** · PHASE1 · COMPLETED · sponsor: **ORIC Pharmaceuticals** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ORIC-101

## Key facts

- **NCT ID:** NCT03324555
- **Lead sponsor:** ORIC Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-19
- **Primary completion:** 2017-12-18
- **Final completion:** 2017-12-18
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03324555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03324555, "Study of ORIC-101 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03324555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*